Press-release for stocks related to bioscience

Prices are updated after-hours

tags : Bioscience crawled time : 22:00

save search

Aadi Bioscience Announces Publication of Long-Term Efficacy and Safety Data Further Supporting FYARRO® for the Treatment of Malignant PEComa
Published: 2024-03-01 (Crawled : 22:00) - biospace.com/
AADI | $1.835 1.94% 1.91% 140K

Manufacturing

| -9.14% | O: 1.02% H: 0.0% C: 0.0%
fyarro bioscience publication treatment

Harvard Bioscience Schedules Fourth Quarter 2023 Earnings Conference Call for March 7, 2024 at 8:00 AM ET
Published: 2024-02-27 (Crawled : 22:00) - globenewswire.com
HBIO | $3.7 -6.8% -7.3% 87K

Health Technology

| -7.47% | O: -0.9% H: 2.05% C: 0.0%
conference bioscience

Aadi Bioscience Announces Poster Presentations at the 2024 American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium
Published: 2024-01-26 (Crawled : 22:00) - prnewswire.com
AADI | $1.835 1.94% 1.91% 140K

Manufacturing

| Email alert Add to watchlist
symposium bioscience

Daré Bioscience Announces Executive Team and Board of Directors Changes
Published: 2024-01-26 (Crawled : 22:00) - globenewswire.com
DARE | $0.2838 -3.83% -3.98% 550K

Health Technology

| Email alert Add to watchlist
bioscience

Aadi Bioscience Announces Poster Presentations at the 2024 American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers Symposium
Published: 2024-01-19 (Crawled : 22:00) - prnewswire.com
AADI | $1.835 1.94% 1.91% 140K

Manufacturing

| Email alert Add to watchlist
symposium bioscience gastrointestinal

Harvard Bioscience to Present at Benchmark Company’s Discovery One-On-One Investor Conference on December 7, 2023
Published: 2023-11-20 (Crawled : 22:00) - globenewswire.com
HBIO | $3.7 -6.8% -7.3% 87K

Health Technology

| -3.08% | O: -0.24% H: 1.9% C: 0.24%
conference bioscience

INVO Bioscience Announces Commencement of Waiver Solicitation From Holders of the Company’s Common Stock Purchase Warrants
Published: 2023-11-09 (Crawled : 22:00) - invobioscience.com
INVO | $1.345 -11.51% -13.01% 1.4M

Health Technology

| 10.63% | O: 89.23% H: 56.92% C: 0.77%
bioscience

Mablink Bioscience Enters an Agreement to be Acquired by Lilly
Published: 2023-10-18 (Crawled : 22:00) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M

Health Technology

| 23.42% | O: -0.18% H: 1.42% C: 0.0%
bioscience acquired agreement

Satellos Bioscience Enters Into an Agreement with ICP Securities Inc. to Provide Market Making Services
Published: 2023-09-07 (Crawled : 22:00) - biospace.com/
MSCLF | $0.3901 18.14% 1K

n/a

| Email alert Add to watchlist
services bioscience agreement market

Harvard Bioscience to Present at Sidoti Virtual Investor Conference on August 16, 2023
Published: 2023-08-03 (Crawled : 22:00) - globenewswire.com
HBIO | $3.7 -6.8% -7.3% 87K

Health Technology

| -15.32% | O: 0.0% H: 2.48% C: 0.0%
conference bioscience

Bloom Burton & Co. Inc. Announces Changes to Holdings in Satellos Bioscience Inc.
Published: 2023-05-17 (Crawled : 22:00) - biospace.com/
MSCLF | $0.3901 18.14% 1K

n/a

| Email alert Add to watchlist
bioscience

Harvard Bioscience Announces Initial Order for Integrated Animal Behavior Monitoring System
Published: 2023-04-18 (Crawled : 22:00) - globenewswire.com
HBIO | $3.7 -6.8% -7.3% 87K

Health Technology

| -13.71% | O: 0.42% H: 0.74% C: 0.0%
animal bioscience system order

Aadi Bioscience to Present Multiple Posters on nab-Sirolimus at the 2023 American Association for Cancer Research (AACR) Annual Meeting
Published: 2023-04-14 (Crawled : 22:00) - biospace.com/
AADI | $1.835 1.94% 1.91% 140K

Manufacturing

| -77.98% | O: -0.12% H: 0.74% C: -0.37%
association bioscience cancer research meeting

INVO Bioscience to Report Fourth Quarter and Fiscal Year 2022 Financial Results on Monday, April 17, 2023
Published: 2023-04-11 (Crawled : 22:00) - prnewswire.com
INVO | $1.345 -11.51% -13.01% 1.4M

Health Technology

| 46.07% | O: 3.79% H: 0.0% C: -1.52%
report year bioscience financial results

INVO Bioscience Announces Closing of $3.0 Million Registered Direct Offering
Published: 2023-03-27 (Crawled : 22:00) - prnewswire.com
INVO | $1.345 -11.51% -13.01% 1.4M

Health Technology

| 24.59% | O: -3.23% H: 8.86% C: 2.49%
direct bioscience offering

TWST Investors Have Opportunity to Lead Twist Bioscience Corporation Securities Fraud Lawsuit
Published: 2023-01-27 (Crawled : 22:00) - prnewswire.com
TWST | $27.92 -1.55% -1.58% 1.1M

Health Technology

| Email alert Add to watchlist
NEO | $13.54 -1.67% -1.7% 770K

Health Services

| Email alert Add to watchlist
BLRX | $0.6564 2.55% 2.48% 190K

Health Technology

| Email alert Add to watchlist
corporation bioscience

TWST Investors Have Opportunity to Lead Twist Bioscience Corporation Securities Fraud Lawsuit
Published: 2023-01-09 (Crawled : 22:00) - prnewswire.com
FXLV | $0.0975 0.0% 5.1M

Arts, Entertainment, and Recrea...

| -96.9% | O: 0.0% H: 6.13% C: 1.29%
TWST | $27.92 -1.55% -1.58% 1.1M

Health Technology

| 15.86% | O: -0.28% H: 7.69% C: 5.78%
NEO | $13.54 -1.67% -1.7% 770K

Health Services

| 37.6% | O: -0.2% H: 5.53% C: 5.13%
corporation bioscience

Yield10 Bioscience Announces Third Quarter 2022 Financial Results
Published: 2022-11-14 (Crawled : 22:00) - globenewswire.com
YTEN | $0.252 -7.59% -8.21% 280K

Health Technology